Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
Authors
Keywords
-
Journal
BMC Neurology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-03
DOI
10.1186/s12883-020-01808-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
- (2019) Kazunori Toyoda et al. LANCET NEUROLOGY
- Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset
- (2019) Junya Aoki et al. Journal of the American Heart Association
- Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
- (2018) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
- (2018) Qiukui Hao et al. BMJ-British Medical Journal
- Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
- (2016) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke
- (2016) Keun-Sik Hong et al. STROKE
- Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
- (2013) Ka Sing Lawrence Wong et al. CIRCULATION
- Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: Rationale and design
- (2013) S. Claiborne Johnston et al. International Journal of Stroke
- Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
- (2013) Yongjun Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiplatelet Drugs
- (2012) John W. Eikelboom et al. CHEST
- Cilostazol combined with aspirin prevents early neurological deterioration in patients with acute ischemic stroke: A pilot study
- (2011) Tomomi Nakamura et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event
- (2010) Yongjun Wang et al. AMERICAN HEART JOURNAL
- Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial
- (2010) Ka Sing Lawrence Wong et al. LANCET NEUROLOGY
- Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial
- (2010) Reinhard Dengler et al. LANCET NEUROLOGY
- Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke
- (2010) Philip M.W. Bath et al. STROKE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now